EP0757553B1 - Einstückige appliziervorrichtung zur kontaminationsfreien verabreichung von arzneimitteln (zytostatika) - Google Patents

Einstückige appliziervorrichtung zur kontaminationsfreien verabreichung von arzneimitteln (zytostatika) Download PDF

Info

Publication number
EP0757553B1
EP0757553B1 EP95917950A EP95917950A EP0757553B1 EP 0757553 B1 EP0757553 B1 EP 0757553B1 EP 95917950 A EP95917950 A EP 95917950A EP 95917950 A EP95917950 A EP 95917950A EP 0757553 B1 EP0757553 B1 EP 0757553B1
Authority
EP
European Patent Office
Prior art keywords
dispensing device
container
coupling member
piece
piece dispensing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP95917950A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0757553A1 (de
Inventor
Harry Leibitzki
Marina Menz
Norbert Neubauer
Sebastian Vogt
Gerhard Wienzek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menz Marina
Primed Halberstadt Medizintechnik GmbH
Original Assignee
Menz Marina
Primed Halberstadt Medizintechnik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27206544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0757553(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9407022U external-priority patent/DE9407022U1/de
Priority claimed from DE19944422960 external-priority patent/DE4422960C2/de
Priority claimed from DE19944433669 external-priority patent/DE4433669C2/de
Application filed by Menz Marina, Primed Halberstadt Medizintechnik GmbH filed Critical Menz Marina
Publication of EP0757553A1 publication Critical patent/EP0757553A1/de
Application granted granted Critical
Publication of EP0757553B1 publication Critical patent/EP0757553B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1475—Inlet or outlet ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2058—Connecting means having multiple connecting ports
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents

Definitions

  • the invention relates to a one-piece application device for contamination-free Administration of drugs (cytostatics), in particular used in outpatient treatment.
  • drugs cytostatics
  • the connector described in EP 0 363 770 consists essentially of a tubular coupling part and a this final shut-off device.
  • Coupling part consisting of a hollow piercing mandrel and one itself then insertable into a tubular connector of a container hollow part together by an externally detachable Shut-off device is completed.
  • are also off US Pat. No. 4,675,020 and EP 0 028 198 connectors are known, but they are also known do not correct the contamination problem in the desired manner and beyond, like the others described Solutions, just connecting two with pharmaceutical Allow solutions of filled containers. This implies that this Solutions are not, or only partially applicable, e.g. if the Dissolution of a preparation, for example, requires two solvents.
  • the invention has for its object an application device for Compound containing medication (cytostatics) Administration instruments indicate the contamination of the Environment of the drug container during its connection up towards disposal without major technical outlay guaranteed.
  • Compound containing medication cytostatics
  • Administration instruments indicate the contamination of the Environment of the drug container during its connection up towards disposal without major technical outlay guaranteed.
  • the object of the invention is achieved by the features of claim 1 solved.
  • the invention provides an application device Available, especially for outpatient treatments Application comes and no high demands on the medical technology personnel in their use and this by Exposes contamination problems.
  • FIG. 1 shows an application device which consists of a coupling part 1 exists, which includes a spike 2.
  • This coupling part is inseparable from a hose connection 3, 31 with a flexible, When using the arrangement for the first time, only fill it with a gas.
  • Container 4 cannot be removed by gluing or Weld connected.
  • shut-off valve 5 is provided inside the hose connection.
  • the flexible container 4 one, also inextricably linked to it hose-like drain 6.
  • the drain 6 is another mechanical Shut-off valve 7 arranged integrated.
  • Connection tubes to the patient e.g. also usual Catheter, connectable.
  • the coupling part 1 in turn consists of a Pot-shaped, inelastic hollow body 11, which has an inner receiving profile 12 has.
  • the hollow body 11 is advantageously also not shown elastic sealant lined.
  • the admission profile 12 is tapered inwards and has barbed surfaces 13.
  • a drug cytostatics
  • the bottleneck of the coupling part 1 can be included, is indicated schematically in Fig. 3 Medicament container 100 inserted into the coupling part 1 and pressed on.
  • the relative height is the depth of penetration of the piercing mandrel 2 to the barb surfaces 13 so that when the Spike 2 penetrated the puncture base of the medicament container 100 has, the barb surfaces 13 immediately in corresponding Engage the mating surfaces of the bottle neck of the drug container 100 and thus inseparably connect it to the coupling part 1. This ensures that during the connection and the subsequent infusion to be carried out by neither the medical personnel still the environment with leaking from the drug container Aerosols or similar be contaminated.
  • a mechanically operated Shut-off valve 5 the way to, e.g. air-filled, sterile, flexible Container 4 released.
  • the air can enter the drug container 100 pressed and then the required, metered amount of aspirated or drained liquid drug in the container 4 become. Only then is the route of the drug to the patient the hose-like drain 6 through the mechanical shut-off valve 7 openable, released.
  • FIG. 1 A further embodiment of the invention is shown in FIG differs from the embodiment according to FIG. 1 by a different design of the hose connector 31 along a line X-X differs.
  • the two hose connections 32 each provided with a coupling part 1, which is analogous to that shown in FIG. 1 are described.
  • This version is used in particular Administration of drugs (cytostatics) in solid form, such as Powders are available.
  • the procedure is as follows: First, the first coupling part 1 with a container that a corresponding solvent and then the second Coupling part 1 with a container containing the drug to be dissolved includes connected.
  • shut-off valve 51 After opening the shut-off valve 51 one arrives Predeterminable amount of the solvent in the flexible container 4, at The shut-off valves 7 and 5 are in the closed position Shutoff valve 51 closed and the shutoff valve 5 opened to the To clear the way to the container with the drug to be dissolved (cytostatics), the flexible container 4 is pressurized. To the dissolved medicament can be placed in the container 4 get back. The shut-off valves 5 and 51 are closed Position transferred and the administration of the dissolved drug can be done analogously, as described in Fig. 1. Of course 2 can also be used for dosed mixing of two liquid drugs, the container on the first and second coupling part 1 can be connected.
  • FIG. 3 shows a particularly advantageous application device according to the invention, which consists of a coupling part 1, which also contains a piercing mandrel 2.
  • This coupling part 1 is inseparably connected by means of a hose connection 31 to a flexible, self-supporting container 41 filled with a gas by gluing or welding.
  • a mechanically actuated shut-off valve 5 is provided within the hose connection.
  • the aforementioned container 41 carries, analogously to FIG. 1, a hose-like drain 6, which is also inseparably connected to it, within which a further mechanical shut-off valve 7 is integrated.
  • a second hose connection 32 branches off from the hose connection 31 and is also non-detachably connected thereto, to which a check valve 52 is connected as a mechanical shut-off valve, which has a blocking effect against the direction of the flexible container 41.
  • the check valve 52 is provided with a connecting piece 521 for receiving a conical connecting piece 9.
  • This connection piece 521 is preferably designed as a Luer lock connection, which is used in particular for receiving a conical outlet end of a conventional syringe.
  • an analog shut-off valve 5 can be provided between the check valve 52 and the hose connection 31.
  • the Luer lock connection is preferably designed such that it engages in the check valve itself in such a way that it causes the same to open when connected to the conical syringe outlet end 9.
  • the proposed embodiment is used in particular for the administration of medicaments (cytostatics) which are available in solid form, such as powders.
  • the procedure is as follows: first, the container 100, which contains the medicament to be dissolved, is connected to the coupling part 1 by pressing in the direction of the arrow. The path to the hose connection 31 is kept closed by the shut-off valve 5.
  • a syringe which can be filled, usually with saline solution, is variable, depending on the amount to be dissolved, of the drug present in solid form, with its conical outlet end 9 with the Luer lock connection 521, the nonreturn valve 52 being opened.
  • the solvent can now be introduced into the flexible, self-supporting container 41 filled with a gas, preferably air.
  • the syringe is removed, the check valve 52 ensuring the contamination-free closure to the outside. If the syringe or other storage container for the solvent remains in the connected position, a further shut-off valve 5 must be provided between the check valve 52 and the hose connection 31, which would have to be closed after the solvent has been introduced into the container 41.
  • shut-off valve 5 Only then is the first shut-off valve 5 to the coupling part 1 opened, the defined, predetermined amount of the solvent pressed into the container with the drug to be dissolved, and the solution passed into the container 41 after dissolution.
  • the drug container 100 remains inseparably and sealingly connected to the part 1, the first shut-off valve 5 is closed. It is within the scope of the invention to design the shut-off valve 5 as a three-way valve which is introduced into the container 41 immediately before the hose connection 31 occurs.
  • the released medicinal product is released to the patient by opening the shut-off valve 7.
  • FIG. 4 shows a coupling part 1, partly in section, in more detail shown.
  • all of the designated parts are: piercing mandrel 2, Hollow body 11, receiving profile 12 and a connector 8, preferably made of plastic, in one piece trained, i.e. the spike 2 is also an integral part of the Coupling part 1.
  • the entire coupling part 1 as Manufacture uniform molded part.
  • the essence of the invention is not to the number of those described Connections limited. In any case, it is essential that a flexible container 4, 41 filled with a gas is used, the one with at least two connecting lines that can be optionally opened and closed to defined coupling means or in the direction the drug delivery is provided.
  • the entire Application device that already with a gas (preferably air) filled containers includes to be provided in sterilized form.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95917950A 1994-04-28 1995-04-25 Einstückige appliziervorrichtung zur kontaminationsfreien verabreichung von arzneimitteln (zytostatika) Expired - Lifetime EP0757553B1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE9407022U 1994-04-28
DE9407022U DE9407022U1 (de) 1994-04-28 1994-04-28 Konnektor zur kontaminationsfreien Verabreichung von Arzneimitteln (Zytostatika)
DE4422960 1994-06-29
DE19944422960 DE4422960C2 (de) 1994-04-28 1994-06-29 Einstückige Appliziervorrichtung zur kontaminationsfreien Verabreichung von Arzneimitteln, insbesondere Zytostatika
DE4433669 1994-09-21
DE19944433669 DE4433669C2 (de) 1994-04-28 1994-09-21 Einstückige Appliziervorrichtung zur kontaminationsfreien Verabreichung von in fester Ausgangsform vorliegenden Arzneimitteln, insbesondere Zytostatika
PCT/EP1995/001547 WO1995029661A1 (de) 1994-04-28 1995-04-25 Einstückige appliziervorrichtung zur kontaminationsfreien verabreichung von arzneimitteln (zytostatika)

Publications (2)

Publication Number Publication Date
EP0757553A1 EP0757553A1 (de) 1997-02-12
EP0757553B1 true EP0757553B1 (de) 2000-08-02

Family

ID=27206544

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95917950A Expired - Lifetime EP0757553B1 (de) 1994-04-28 1995-04-25 Einstückige appliziervorrichtung zur kontaminationsfreien verabreichung von arzneimitteln (zytostatika)

Country Status (6)

Country Link
US (1) US5899877A (fi)
EP (1) EP0757553B1 (fi)
AT (1) ATE195071T1 (fi)
CA (1) CA2188953A1 (fi)
FI (1) FI964252A0 (fi)
WO (1) WO1995029661A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030032935A1 (en) * 2001-08-10 2003-02-13 Scimed Life Systems, Inc. Packages facilitating convenient mixing and delivery of liquids
US7462366B2 (en) 2002-03-29 2008-12-09 Boston Scientific Scimed, Inc. Drug delivery particle
US7053134B2 (en) * 2002-04-04 2006-05-30 Scimed Life Systems, Inc. Forming a chemically cross-linked particle of a desired shape and diameter
WO2003105917A2 (en) * 2002-06-12 2003-12-24 Scimed Life Systems, Inc. Bulking agents
US7842377B2 (en) 2003-08-08 2010-11-30 Boston Scientific Scimed, Inc. Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US8012454B2 (en) 2002-08-30 2011-09-06 Boston Scientific Scimed, Inc. Embolization
US7883490B2 (en) 2002-10-23 2011-02-08 Boston Scientific Scimed, Inc. Mixing and delivery of therapeutic compositions
US7976823B2 (en) * 2003-08-29 2011-07-12 Boston Scientific Scimed, Inc. Ferromagnetic particles and methods
US7736671B2 (en) * 2004-03-02 2010-06-15 Boston Scientific Scimed, Inc. Embolization
US8173176B2 (en) 2004-03-30 2012-05-08 Boston Scientific Scimed, Inc. Embolization
US7311861B2 (en) 2004-06-01 2007-12-25 Boston Scientific Scimed, Inc. Embolization
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7858183B2 (en) 2005-03-02 2010-12-28 Boston Scientific Scimed, Inc. Particles
US7727555B2 (en) 2005-03-02 2010-06-01 Boston Scientific Scimed, Inc. Particles
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US8007509B2 (en) 2005-10-12 2011-08-30 Boston Scientific Scimed, Inc. Coil assemblies, components and methods
US8152839B2 (en) 2005-12-19 2012-04-10 Boston Scientific Scimed, Inc. Embolic coils
US8101197B2 (en) 2005-12-19 2012-01-24 Stryker Corporation Forming coils
US7947368B2 (en) 2005-12-21 2011-05-24 Boston Scientific Scimed, Inc. Block copolymer particles
BRPI0714879A2 (pt) * 2006-07-21 2013-02-26 Polimoom Medical Packaging As dispositivo de conector e mÉtodo para mistura estÉril
US8414927B2 (en) 2006-11-03 2013-04-09 Boston Scientific Scimed, Inc. Cross-linked polymer particles
US9138552B2 (en) * 2007-06-05 2015-09-22 Cedars-Sinai Medical Center Closed suctioning and rinsing methods and tracheal devices
US20090270832A1 (en) * 2008-04-23 2009-10-29 Baxter International Inc. Needleless port assembly for a container
US9084864B1 (en) 2010-03-04 2015-07-21 Barthel LLC Adaptor for breathing tube and method
IT1400708B1 (it) 2010-06-25 2013-06-28 Frattini Paolo Giuseppe Gobbi Dispositivo per la ricostituzione dosata e la somministrazione di soluzioni liquide contenenti sostanze attive disponibili in forma separata, in particolare in polvere o gel.
WO2012117409A1 (en) 2011-02-28 2012-09-07 Vhb Pharmaceuticals Private Limited A needle-free dispending pin for safe drug administration
US8816814B2 (en) 2011-08-16 2014-08-26 Elwha Llc Systematic distillation of status data responsive to whether or not a wireless signal has been received and relating to regimen compliance
WO2023126699A1 (en) * 2021-12-30 2023-07-06 Paolo Gobbi Frattini S.R.L. Pressure compensation device for reconstitution, withdrawal and transfer of a drug from a vial or other vacuum container, and apparatus comprising the above said device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4114617A (en) * 1977-02-28 1978-09-19 Turner Thomas D Apparatus for infusion of a measured volume of blood
US4200095A (en) * 1977-08-15 1980-04-29 Millipore Corporation Arrangement for intravenous administration or the like
FR2468059A1 (fr) * 1979-10-16 1981-04-30 Aguettant Lab Dispositif a usage medical de connexion avec etancheite entre deux embouts en vue de la mise en communication de deux volumes
US4705505A (en) * 1984-09-28 1987-11-10 Fried Steven J Rapid solution administration set with integral heat exchanger
US4675020A (en) * 1985-10-09 1987-06-23 Kendall Mcgaw Laboratories, Inc. Connector
EP0273015A3 (fr) * 1986-12-24 1988-10-05 Vifor S.A. Récipient avec dispositif récepteur d'une fioline
US4863454A (en) * 1987-10-16 1989-09-05 Labove Larry D Dual bag intravenous preparation system
SE8800337L (sv) * 1988-02-03 1989-08-04 Astra Ab Anordning foer blandning och/eller oeverfoering av ett aemne
DE8802443U1 (de) * 1988-02-25 1988-09-01 Schiwa GmbH, 4519 Glandorf Behälter für Infusionslösungen
DE8812460U1 (de) * 1988-10-03 1988-12-22 Schiwa GmbH, 4519 Glandorf Konnektor für einen Behälter für pharmazeutische Lösungen
US4997430A (en) * 1989-09-06 1991-03-05 Npbi Nederlands Produktielaboratorium Voor Bloedtransfusieapparatuur En Infusievloeistoffen B.V. Method of and apparatus for administering medicament to a patient
US4973328A (en) * 1989-11-20 1990-11-27 Gerard Smith Closed system administering assembly
US5368586A (en) * 1991-06-21 1994-11-29 Npbi Nederlands Produktielaboratorium Voor Bloedtransfusieapparatuur En Infusievloeistoffen B.V. Closure for a drug-vial
US5242392A (en) * 1992-02-13 1993-09-07 Vaughn Dale T Intravenous piggyback flush apparatus

Also Published As

Publication number Publication date
ATE195071T1 (de) 2000-08-15
FI964252A (fi) 1996-10-22
CA2188953A1 (en) 1995-11-09
WO1995029661A1 (de) 1995-11-09
FI964252A0 (fi) 1996-10-22
EP0757553A1 (de) 1997-02-12
US5899877A (en) 1999-05-04

Similar Documents

Publication Publication Date Title
EP0757553B1 (de) Einstückige appliziervorrichtung zur kontaminationsfreien verabreichung von arzneimitteln (zytostatika)
DE68909402T2 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz.
DE60315003T2 (de) Flüssigkeitstransfer-anordnung
DE69009634T2 (de) Methode und Gerät, einem Patienten ein Medikament zu verabreichen.
DE69626135T2 (de) Vorrichtung zur applikation einer mehrkomponentenflüssigkeit
DE69839128T2 (de) Spenderanordnung
DE68908700T2 (de) Aufbewahrungs- und umfüllflasche zum aufbewahren von zwei bestandteilen einer heilkräftigen substanz.
DE69623268T2 (de) Vorgefüllte spritze zur verabreichung von medikamenten
DE69613461T2 (de) Durchflussregelvorrichtung
DE69413378T2 (de) ABGABESYSTEM FüR MEDIKAMENTE
DE69231208T2 (de) Medizinisches ventil
DE69828281T2 (de) Subkutaninfusionsvorrichtung
DE69323729T2 (de) Adaptor fuer eine medikamentabgabevorrichtung
DE3143329C2 (de) Schutzvorrichtung für einen Verbindungsstöpsel von medizinischen Schlauchsystemen
EP0390898B1 (de) Behälter zur getrennten, sterilen aufbewahrung mindestens zweier substanzen und zur vermischung dieser substanzen
WO1988003815A1 (en) Multi-path valve for a device for producing or administering infusion solutions
DE3627231C2 (de) Überleitungsgerät zum Mischen von in unterschiedlichen Behältern befindlichen Medikamenten
DE69904350T2 (de) Behaelter für intravenöse applikation
DE102009023676B4 (de) Vorrichtung zur Applikation fluidaler Medikamente
DE60116409T2 (de) Medizinische, vorgefertigte Einmalvorrichtung zum Verabreichen von mindestens zwei Medikamenten im vorgegebenen Verhältnis
EP0330130A2 (de) Behälter für Infusionslösungen
EP0363770A1 (de) Konnektor für einen Behälter für pharmazeutische Lösungen
DE69723278T2 (de) Pharmazeutische ampulle
DE102008045692A1 (de) Vorrichtung und Verfahren zum Anlegen eines Zugangs zu einem Hohlorgan, Werkzeug
EP2537772A1 (de) Vorrichtung zur Aufnahme und Abgabe eines Fluids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

RBV Designated contracting states (corrected)

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

17P Request for examination filed

Effective date: 19961024

17Q First examination report despatched

Effective date: 19971202

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MENZ, MARINA

Owner name: PRIMED HALBERSTADT MEDIZINTECHNIK GMBH

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20000802

Ref country code: ES

Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY

Effective date: 20000802

REF Corresponds to:

Ref document number: 195071

Country of ref document: AT

Date of ref document: 20000815

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: GERMAN

REF Corresponds to:

Ref document number: 59508613

Country of ref document: DE

Date of ref document: 20000907

ITF It: translation for a ep patent filed
GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20001005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20001102

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20001102

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20001102

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20001103

ET Fr: translation filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010419

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20010430

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLBI Opposition filed

Free format text: ORIGINAL CODE: 0009260

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

26 Opposition filed

Opponent name: ONKOPHARM ARZNEIMITTEL GMBH

Effective date: 20010430

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

BERE Be: lapsed

Owner name: MENZ MARINA

Effective date: 20010430

Owner name: PRIMED HALBERSTADT MEDIZINTECHNIK G.M.B.H.

Effective date: 20010430

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PLBF Reply of patent proprietor to notice(s) of opposition

Free format text: ORIGINAL CODE: EPIDOS OBSO

PLAY Examination report in opposition despatched + time limit

Free format text: ORIGINAL CODE: EPIDOSNORE2

PLBC Reply to examination report in opposition received

Free format text: ORIGINAL CODE: EPIDOSNORE3

PLBQ Unpublished change to opponent data

Free format text: ORIGINAL CODE: EPIDOS OPPO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

R26 Opposition filed (corrected)

Opponent name: ONKOPHARM ARZNEIMITTEL GMBH

Effective date: 20010430

PLCK Communication despatched that opposition was rejected

Free format text: ORIGINAL CODE: EPIDOSNREJ1

APBP Date of receipt of notice of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA2O

APBQ Date of receipt of statement of grounds of appeal recorded

Free format text: ORIGINAL CODE: EPIDOSNNOA3O

APAA Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFN

APAH Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

PLAB Opposition data, opponent's data or that of the opponent's representative modified

Free format text: ORIGINAL CODE: 0009299OPPO

APBU Appeal procedure closed

Free format text: ORIGINAL CODE: EPIDOSNNOA9O

R26 Opposition filed (corrected)

Opponent name: ONKOPHARM ARZNEIMITTEL GMBH

Effective date: 20010430

R26 Opposition filed (corrected)

Opponent name: ONKOPHARM ARZNEIMITTEL GMBH

Effective date: 20010430

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20060315

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20060317

Year of fee payment: 12

PLBN Opposition rejected

Free format text: ORIGINAL CODE: 0009273

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: OPPOSITION REJECTED

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20060403

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20060419

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060430

Year of fee payment: 12

27O Opposition rejected

Effective date: 20060207

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070430

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070430

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070425

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070425

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20140508

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 59508613

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 59508613

Country of ref document: DE